GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » Change In Receivables

Ferozsons Laboratories (KAR:FEROZ) Change In Receivables : ₨-877 Mil (TTM As of Mar. 2025)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories Change In Receivables?

Ferozsons Laboratories's change in receivables for the quarter that ended in Mar. 2025 was ₨-100 Mil. It means Ferozsons Laboratories's Accounts Receivable increased by ₨100 Mil from Dec. 2024 to Mar. 2025 .

Ferozsons Laboratories's change in receivables for the fiscal year that ended in Jun. 2024 was ₨-1,559 Mil. It means Ferozsons Laboratories's Accounts Receivable increased by ₨1,559 Mil from Jun. 2023 to Jun. 2024 .

Ferozsons Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was ₨3,116 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ferozsons Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 55.83.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ferozsons Laboratories's liquidation value for the three months ended in Mar. 2025 was ₨-2,837 Mil.


Ferozsons Laboratories Change In Receivables Historical Data

The historical data trend for Ferozsons Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories Change In Receivables Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -169.01 -439.23 -60.17 91.19 -1,559.00

Ferozsons Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 196.61 -241.12 -859.68 323.78 -99.80

Ferozsons Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-877 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ferozsons Laboratories  (KAR:FEROZ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ferozsons Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3115.506/5091.897*91
=55.83

2. In Ben Graham's calculation of liquidation value, Ferozsons Laboratories's accounts receivable are only considered to be worth 75% of book value:

Ferozsons Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2113.985-10224.605+0.75 * 3115.506+0.5 * 5874.603
=-2,837

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ferozsons Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines